1931 logo

ETHK Labs Inc. Stock Price

SEHK:1931 Community·HK$1.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1931 Share Price Performance

HK$0
-2.00 (-100.00%)
HK$0
-2.00 (-100.00%)
Price HK$0

1931 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks
0 Rewards

ETHK Labs Inc. Key Details

CN¥2.8b

Revenue

CN¥2.3b

Cost of Revenue

CN¥566.4m

Gross Profit

CN¥531.4m

Other Expenses

CN¥34.9m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.022
20.08%
1.24%
61.2%
View Full Analysis

About 1931

Founded
2016
Employees
910
CEO
Xianya Lin
WebsiteView website
www.ethk.com

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analysers and reagents. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. The company was formerly known as IVD Medical Holding Limited and change its name to ETHK Labs Inc. in December 2025. ETHK Labs Inc. was incorporated in 2016 and is headquartered in Shanghai, the People's Republic of China.

Recent 1931 News & Updates

Recent updates

No updates